(CFR) Cullen/Frost Bankers - Ratings and Ratios
Banking, Loans, Deposits, Trust, Insurance
CFR EPS (Earnings per Share)
CFR Revenue
Description: CFR Cullen/Frost Bankers
Cullen/Frost Bankers, Inc. (NYSE:CFR) is a bank holding company operating Frost Bank, which provides a comprehensive range of commercial and consumer banking services primarily in Texas. The companys diverse offerings cater to various industries, including energy, manufacturing, and healthcare, providing financing solutions, treasury management, and investment services.
From a business perspective, CFRs strength lies in its ability to serve both corporate and individual clients through a broad array of services, including international banking, trust and investment management, and capital market services. The banks long history, dating back to 1868, and its headquarters in San Antonio, Texas, position it as a significant player in the regional banking landscape.
Key Performance Indicators (KPIs) that can be used to evaluate CFRs performance include its efficiency ratio, which measures the banks ability to manage expenses relative to revenue, and its net interest margin, indicating the profitability of its lending and deposit activities. Additionally, the banks loan growth rate and deposit growth rate are crucial in assessing its ability to expand its customer base and increase its revenue. CFRs return on equity (RoE) of 15.12% is a notable metric, suggesting a strong ability to generate profits from shareholders equity.
To further analyze CFRs potential, one could examine its asset quality metrics, such as the non-performing assets (NPA) ratio and the allowance for loan losses (ALL) as a percentage of total loans. These metrics provide insights into the banks credit risk management and its ability to absorb potential losses. Furthermore, CFRs capital adequacy ratio and its dividend payout ratio are important indicators of its financial health and its commitment to returning value to shareholders.
Additional Sources for CFR Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
CFR Stock Overview
Market Cap in USD | 8,697m |
Sector | Financial Services |
Industry | Banks - Regional |
GiC Sub-Industry | Regional Banks |
IPO / Inception | 1990-03-26 |
CFR Stock Ratings
Growth Rating | 48.2 |
Fundamental | 46.8 |
Dividend Rating | 64.7 |
Rel. Strength | -6.1 |
Analysts | 2.92 of 5 |
Fair Price Momentum | 116.38 USD |
Fair Price DCF | 11.06 USD |
CFR Dividends
Dividend Yield 12m | 3.07% |
Yield on Cost 5y | 6.21% |
Annual Growth 5y | 5.59% |
Payout Consistency | 82.0% |
Payout Ratio | 42.3% |
CFR Growth Ratios
Growth Correlation 3m | 60.3% |
Growth Correlation 12m | 37% |
Growth Correlation 5y | 43.8% |
CAGR 5y | 14.90% |
CAGR/Max DD 5y | 0.33 |
Sharpe Ratio 12m | 0.07 |
Alpha | -2.53 |
Beta | 1.019 |
Volatility | 26.80% |
Current Volume | 973.9k |
Average Volume 20d | 311.8k |
Stop Loss | 120.5 (-3%) |
As of August 02, 2025, the stock is trading at USD 124.20 with a total of 973,939 shares traded.
Over the past week, the price has changed by -7.95%, over one month by -6.27%, over three months by +4.01% and over the past year by +13.61%.
Partly, yes. Based on ValueRay´s Fundamental Analyses, Cullen/Frost Bankers (NYSE:CFR) is currently (August 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 46.80 and therefor a somewhat positive outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CFR is around 116.38 USD . This means that CFR is currently overvalued and has a potential downside of -6.3%.
Cullen/Frost Bankers has received a consensus analysts rating of 2.92. Therefor, it is recommend to hold CFR.
- Strong Buy: 1
- Buy: 1
- Hold: 9
- Sell: 0
- Strong Sell: 2
According to our own proprietary Forecast Model, CFR Cullen/Frost Bankers will be worth about 136 in August 2026. The stock is currently trading at 124.20. This means that the stock has a potential upside of +9.48%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 135.5 | 9.1% |
Analysts Target Price | 131.6 | 6% |
ValueRay Target Price | 136 | 9.5% |